Clinical Trial Update: Study of ORL-1F (L-fucose) in Patients With Leukocyte Adhesion Deficiency Type II [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating ORL-1F (L-fucose) in patients with Leukocyte adhesion deficiency, type II has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukocyte Adhesion Deficiency Type Ii

Drugs mentioned

• ORL-1F (L-fucose) (L-fucose)

Snippet

Sponsor: Orpha Labs | Conditions: Leukocyte Adhesion Deficiency, Type II | Phase 1, Phase 2 | Status: COMPLETED